Lb Pharmaceuticals (LBRX) Net Cash Flow (2024 - 2026)

Lb Pharmaceuticals' Net Cash Flow history runs 3 years deep, the most recent figure standing at $70.5 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 2339.8% year-over-year to $70.5 million; the TTM figure through Mar 2026 stood at $48.1 million (changed N/A YoY), while the FY2025 annual figure was $227.5 million, up 2577.12% from the prior year.
• Net Cash Flow was $70.5 million for Q1 2026 at Lb Pharmaceuticals, up from -$19.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $70.5 million in Q1 2026 to a low of -$19.3 million in Q4 2025.
• Historically, Net Cash Flow has averaged $14.0 million across 3 years, with a median of $2.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Net Cash Flow slumped 345.27% in 2025, then surged 2339.8% in 2026.
• A 3-year view of Net Cash Flow shows it stood at $7.9 million in 2024, then tumbled by 345.27% to -$19.3 million in 2025, then surged by 465.14% to $70.5 million in 2026.
• The last three Net Cash Flow figures came in at $70.5 million (Q1 2026), -$19.3 million (Q4 2025), and -$3.1 million (Q1 2025), per Business Quant data.